On the public citation graph

Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma

0 signed · 143 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/0471142735.im2001s39openalex-snapshot
B16 as a Mouse Model for Human Melanoma
inferredcites →https://doi.org/10.1007/s12014-010-9055-yopenalex-snapshot
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
inferredcites →https://doi.org/10.1016/j.bbrc.2007.06.159openalex-snapshot
SIRPα1 and SIRPα2: Their role as tumor suppressors in breast carcinoma cells
inferredcites →https://doi.org/10.1016/j.biopha.2020.109821openalex-snapshot
Cancer immunotherapy: Pros, cons and beyond
inferredcites →https://doi.org/10.1016/j.ccell.2017.01.005openalex-snapshot
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
inferredcites →https://doi.org/10.1016/j.ccell.2018.03.017openalex-snapshot
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
inferredcites →https://doi.org/10.1016/j.ccell.2019.01.003openalex-snapshot
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
inferredcites →https://doi.org/10.1016/j.ccell.2021.04.014openalex-snapshot
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
inferredcites →https://doi.org/10.1016/j.ccell.2021.07.004openalex-snapshot
From bench to bedside: Single-cell analysis for cancer immunotherapy
inferredcites →https://doi.org/10.1016/j.ccell.2021.11.012openalex-snapshot
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
inferredcites →https://doi.org/10.1016/j.ccell.2022.05.016openalex-snapshot
The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy
inferredcites →https://doi.org/10.1016/j.ccell.2022.07.006openalex-snapshot
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes
inferredcites →https://doi.org/10.1016/j.cell.2015.08.052openalex-snapshot
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
inferredcites →https://doi.org/10.1016/j.cell.2016.02.065openalex-snapshot
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
inferredcites →https://doi.org/10.1016/j.cell.2017.01.014openalex-snapshot
Applications of Immunogenomics to Cancer
inferredcites →https://doi.org/10.1016/j.cell.2017.09.028openalex-snapshot
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
inferredcites →https://doi.org/10.1016/j.cell.2018.09.006openalex-snapshot
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
inferredcites →https://doi.org/10.1016/j.cell.2018.10.022openalex-snapshot
Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression
inferredcites →https://doi.org/10.1016/j.cell.2018.10.038openalex-snapshot
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
inferredcites →https://doi.org/10.1016/j.cell.2019.08.012openalex-snapshot
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
inferredcites →https://doi.org/10.1016/j.cell.2019.12.023openalex-snapshot
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
inferredcites →https://doi.org/10.1016/j.celrep.2013.03.025openalex-snapshot
Modeling Neural Crest Induction, Melanocyte Specification, and Disease-Related Pigmentation Defects in hESCs and Patient-Specific iPSCs
inferredcites →https://doi.org/10.1016/j.critrevonc.2017.05.001openalex-snapshot
Melanoma antigens and related immunological markers
inferredcites →https://doi.org/10.1016/j.immuni.2020.07.008openalex-snapshot
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
inferredcites →https://doi.org/10.1016/j.stem.2017.08.003openalex-snapshot
Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes
inferredcites →https://doi.org/10.1016/j.stem.2017.09.001openalex-snapshot
Melanocyte Stem Cell Activation and Translocation Initiate Cutaneous Melanoma in Response to UV Exposure
inferredcites →https://doi.org/10.1038/d41573-020-00204-yopenalex-snapshot
Combinations take centre stage in PD1/PDL1 inhibitor clinical trials
inferredcites →https://doi.org/10.1038/nature11538openalex-snapshot
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
inferredcites →https://doi.org/10.1038/nature14136openalex-snapshot
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
inferredcites →https://doi.org/10.1038/ncomms10707openalex-snapshot
Correction: Corrigendum: Systematic pan-cancer analysis of tumour purity
inferredcites →https://doi.org/10.1038/ncomms4887openalex-snapshot
A pan-cancer proteomic perspective on The Cancer Genome Atlas
inferredcites →https://doi.org/10.1038/ncomms5852openalex-snapshot
Correction: Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome Atlas
inferredcites →https://doi.org/10.1038/ncomms9755openalex-snapshot
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
inferredcites →https://doi.org/10.1038/ncomms9971openalex-snapshot
Systematic pan-cancer analysis of tumour purity
inferredcites →https://doi.org/10.1038/ng1634openalex-snapshot
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
inferredcites →https://doi.org/10.1038/ni.3693openalex-snapshot
Social network architecture of human immune cells unveiled by quantitative proteomics
inferredcites →https://doi.org/10.1038/ni1207-1287openalex-snapshot
Macrophage tolerance: CD47–SIRP-α–mediated signals matter
inferredcites →https://doi.org/10.1038/nmeth.4197openalex-snapshot
Salmon provides fast and bias-aware quantification of transcript expression
inferredcites →https://doi.org/10.1038/nri1859openalex-snapshot
The SIRP family of receptors and immune regulation
inferredcites →https://doi.org/10.1038/s41392-021-00484-9openalex-snapshot
Targeting tumor-associated macrophages to synergize tumor immunotherapy
inferredcites →https://doi.org/10.1038/s41467-019-08637-9openalex-snapshot
A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression
inferredcites →https://doi.org/10.1038/s41556-021-00740-8openalex-snapshot
Human melanocyte development and melanoma dedifferentiation at single-cell resolution
inferredcites →https://doi.org/10.1038/s41587-019-0114-2openalex-snapshot
Determining cell type abundance and expression from bulk tissues with digital cytometry
inferredcites →https://doi.org/10.1038/s41591-019-0654-5openalex-snapshot
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
inferredcites →https://doi.org/10.1038/s41592-019-0619-0openalex-snapshot
Fast, sensitive and accurate integration of single-cell data with Harmony
inferredcites →https://doi.org/10.1038/s41596-020-0292-xopenalex-snapshot
CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
inferredcites →https://doi.org/10.1056/nejmc1713444openalex-snapshot
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
inferredcites →https://doi.org/10.1056/nejmoa1003466openalex-snapshot
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1200690openalex-snapshot
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
inferredcites →https://doi.org/10.1056/nejmoa1411087openalex-snapshot
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1056/nejmoa1414428openalex-snapshot
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
inferredcites →https://doi.org/10.1073/pnas.1121623109openalex-snapshot
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
inferredcites →https://doi.org/10.1073/pnas.1604268113openalex-snapshot
Durable antitumor responses to CD47 blockade require adaptive immune stimulation
inferredcites →https://doi.org/10.1073/pnas.1710877114openalex-snapshot
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
inferredcites →https://doi.org/10.1073/pnas.1921445117openalex-snapshot
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
inferredcites →https://doi.org/10.1074/jbc.m002334200openalex-snapshot
CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation
inferredcites →https://doi.org/10.1080/14712598.2020.1685976openalex-snapshot
Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy
inferredcites →https://doi.org/10.1093/abt/tbaa006openalex-snapshot
Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure–function
inferredcites →https://doi.org/10.1093/annonc/mdx682openalex-snapshot
Informatics for cancer immunotherapy
inferredcites →https://doi.org/10.1093/bioinformatics/btt656openalex-snapshot
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
inferredcites →https://doi.org/10.1093/bioinformatics/btu736openalex-snapshot
Development of a robust classifier for quality control of reverse-phase protein arrays
inferredcites →https://doi.org/10.1093/bioinformatics/btw318openalex-snapshot
TarPmiR: a new approach for microRNA target site prediction
inferredcites →https://doi.org/10.1093/emboj/cdg278openalex-snapshot
Role of the CD47–SHPS‐1 system in regulation of cell migration
inferredcites →https://doi.org/10.1093/nar/gkl243openalex-snapshot
RNAhybrid: microRNA target prediction easy, fast and flexible
inferredcites →https://doi.org/10.1093/nar/gku1104openalex-snapshot
miRDB: an online resource for microRNA target prediction and functional annotations
inferredcites →https://doi.org/10.1093/nar/gkz757openalex-snapshot
miRDB: an online database for prediction of functional microRNA targets
inferredcites →https://doi.org/10.1097/md.0000000000022153openalex-snapshot
Treatment-related adverse events as surrogate to response rate to immune checkpoint blockade
inferredcites →https://doi.org/10.1097/pas.0000000000000527openalex-snapshot
Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma)
inferredcites →https://doi.org/10.1111/jcmm.13956openalex-snapshot
Tumour cell‐intrinsic CTLA 4 regulates PD ‐L1 expression in non‐small cell lung cancer
inferredcites →https://doi.org/10.1126/science.aad0501openalex-snapshot
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
inferredcites →https://doi.org/10.1126/science.aao1710openalex-snapshot
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
inferredcites →https://doi.org/10.1126/science.abi8175openalex-snapshot
Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment
inferredcites →https://doi.org/10.1158/0008-5472.can-18-0747openalex-snapshot
Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-3122openalex-snapshot
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
inferredcites →https://doi.org/10.1158/1078-0432.ccr-16-1688openalex-snapshot
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-21-1694openalex-snapshot
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases
inferredcites →https://doi.org/10.1158/2159-8290.cd-17-1178openalex-snapshot
Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1172/jci.insight.89140openalex-snapshot
Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy
inferredcites →https://doi.org/10.1172/jci123396openalex-snapshot
A-to-I–edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis
inferredcites →https://doi.org/10.1172/jci135528openalex-snapshot
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
inferredcites →https://doi.org/10.1182/blood.v97.9.2741openalex-snapshot
Signal-regulatory protein α (SIRPα) but not SIRPβ is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38−hematopoietic cells
inferredcites →https://doi.org/10.1186/1471-2105-14-7openalex-snapshot
GSVA: gene set variation analysis for microarray and RNA-Seq data
inferredcites →https://doi.org/10.1186/s13045-020-00989-wopenalex-snapshot
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
inferredcites →https://doi.org/10.1186/s13059-017-1382-0openalex-snapshot
SCANPY: large-scale single-cell gene expression data analysis
inferredcites →https://doi.org/10.1186/s13059-022-02817-5openalex-snapshot
Exploring functional protein covariation across single cells using nPOP
inferredcites →https://doi.org/10.1371/journal.pone.0006529openalex-snapshot
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
inferredcites →https://doi.org/10.21037/jtd.2017.02.30openalex-snapshot
Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy
inferredcites →https://doi.org/10.3389/fimmu.2020.00018openalex-snapshot
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
inferredcites →https://doi.org/10.3389/fonc.2019.01380openalex-snapshot
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
inferredcites →https://doi.org/10.3389/fphar.2020.00722openalex-snapshot
PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
inferredcites →https://doi.org/10.4049/jimmunol.161.4.1853openalex-snapshot
Signal-Regulatory Protein Is Selectively Expressed by Myeloid and Neuronal Cells
inferredcites →https://doi.org/10.7554/elife.49020openalex-snapshot
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4628680openalex-extracted
Disruption of CD47-SIRPα Signalling Restores Inflammatory Function in Tumour-Associated Myeloid Derived Suppressor Cells
inferred← citeshttps://doi.org/10.1002/advs.76003openalex-snapshot
Tumor‐Specific Delivery of CD28 siRNA via Lyso‐PC C‐16 Modified Lipid Nanoparticles Overcomes Anti‐PD‐1 Resistance by Remodeling Tumor Microenvironment
inferred← citeshttps://doi.org/10.1002/ctm2.70249openalex-snapshot
Genome‐wide profiling of N6‐methyladenosine‐modified pseudogene‐derived long noncoding RNAs reveals the tumour‐promoting and innate immune‐restraining function of RPS15AP12 in ovarian cancer
inferred← citeshttps://doi.org/10.1007/s12672-024-01357-7openalex-snapshot
Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation
inferred← citeshttps://doi.org/10.1007/s12672-026-04911-7openalex-snapshot
Identification of SLIT3 mutation as a response biomarker for immune checkpoint inhibitor therapy in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.banm.2023.03.019openalex-snapshot
Biomarqueurs prédictifs de la réponse à l’immunothérapie dans les mélanomes
inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189172openalex-snapshot
Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2023.216412openalex-snapshot
SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake
inferred← citeshttps://doi.org/10.1016/j.ccell.2022.10.003openalex-snapshot
Could SIRPA expression predict response to anti-PD-1 immunotherapy?
inferred← citeshttps://doi.org/10.1016/j.cej.2024.148616openalex-snapshot
Low-temperature photothermal-chemotherapy enhancing tumor immunotherapy by tetrahedral framework nucleic acids nanogels based drug delivery system
inferred← citeshttps://doi.org/10.1016/j.celrep.2026.117443openalex-snapshot
Tumor-intrinsic expression of signal regulatory protein α contributes to the suppression of anti-tumor immune responses
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2026.105269openalex-snapshot
The versatility of SIRPα: Novel perspectives on tumor microenvironment regulation and targeted therapy beyond the CD47-SIRPα axis
inferred← citeshttps://doi.org/10.1016/j.dtrs.2026.100027openalex-snapshot
Oral and systemic diseases under the framework of homeostatic medicine
inferred← citeshttps://doi.org/10.1016/j.isci.2024.109546openalex-snapshot
Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells
inferred← citeshttps://doi.org/10.1016/j.isci.2025.114080openalex-snapshot
SIRPB1 is transcriptionally regulated by USF2 and promotes cutaneous malignant melanoma tumorigenicity through SOCS1/STAT3 signaling
inferred← citeshttps://doi.org/10.1016/j.jare.2026.03.036openalex-snapshot
Oral Delivery of siSIRPα via Yeast-Derived β-Glucan Particles Enhances Macrophage-Mediated Antitumor Immunity by Blocking the CD47-SIRPα Axis
inferred← citeshttps://doi.org/10.1016/j.jid.2025.08.044openalex-snapshot
A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma
inferred← citeshttps://doi.org/10.1016/j.omtn.2024.102155openalex-snapshot
Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c03629openalex-snapshot
Modulation of Tumor Microenvironment via Antibody Mediated Precision Delivery of CpG to Myeloid Cell
inferred← citeshttps://doi.org/10.1038/s41392-024-01826-zopenalex-snapshot
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
inferred← citeshttps://doi.org/10.1038/s41467-024-49482-9openalex-snapshot
Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies
inferred← citeshttps://doi.org/10.1038/s41598-023-32547-yopenalex-snapshot
HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models
inferred← citeshttps://doi.org/10.1038/s41598-024-79865-3openalex-snapshot
Preclinical pharmacology characterization of HX009, a novel PD1 x CD47 Bi-specific antibody
inferred← citeshttps://doi.org/10.1038/s44321-026-00413-9openalex-snapshot
Proteome profiles of esophageal squamous cell carcinoma tie mitochondrial complex I to immunotherapy
inferred← citeshttps://doi.org/10.1038/s44321-026-00451-3openalex-snapshot
Targeting CD3L1-NRP2 disarms myeloid-driven tumor immune evasion
inferred← citeshttps://doi.org/10.1093/pnasnexus/pgaf351openalex-snapshot
Impact of SIRPα genotype combinations in recipients and donors on alloimmune response in liver transplantation
inferred← citeshttps://doi.org/10.1097/md.0000000000040569openalex-snapshot
Identification of gene signatures relevant to the efficacy of immune checkpoint inhibitors in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1136/jitc-2023-007286openalex-snapshot
KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells
inferred← citeshttps://doi.org/10.1136/jitc-2023-sitc2023.0196openalex-snapshot
196 Tumor-associated SIRPα expression evaluation in melanoma PDX models via IHC for potential ICI-predictive applications
inferred← citeshttps://doi.org/10.1136/jitc-2023-sitc2023.0543openalex-snapshot
543 Cis-binding/blockade of CD47 by CD47xPD1 BsAb HX009 enhanced PD1 blockade induced T-cell activation
inferred← citeshttps://doi.org/10.1158/0008-5472.can-24-1130openalex-snapshot
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling
inferred← citeshttps://doi.org/10.1177/00220345241305590openalex-snapshot
Tumor-Intrinsic SIRPA Drives Pyroptosis Evasion in Head and Neck Cancer
inferred← citeshttps://doi.org/10.1186/s12935-023-03158-4openalex-snapshot
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
inferred← citeshttps://doi.org/10.1186/s12943-025-02422-7openalex-snapshot
Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer
inferred← citeshttps://doi.org/10.1186/s12967-025-06467-6openalex-snapshot
Genetic and transcriptional insights into immune checkpoint blockade response and survival: lessons from melanoma and beyond
inferred← citeshttps://doi.org/10.1186/s13046-024-02973-5openalex-snapshot
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
inferred← citeshttps://doi.org/10.1186/s40164-025-00709-5openalex-snapshot
FGL1-mediated lymph node metastasis in stage T1 non-small cell lung cancer: therapeutic targeting
inferred← citeshttps://doi.org/10.1245/s10434-024-15649-3openalex-snapshot
Clinical Significance of SIRPα Expression on Tumor-Associated Macrophages in Patients with Lung Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1245/s10434-025-17813-9openalex-snapshot
Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma
inferred← citeshttps://doi.org/10.2217/epi-2023-0139openalex-snapshot
Pyroptosis-Related Lncrna Prognostic Signatures for Cutaneous Melanoma and Tumor Microenvironment Status
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1435187openalex-snapshot
Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1499663openalex-snapshot
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1579184openalex-snapshot
Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1612234openalex-snapshot
Deciphering the role of signal regulatory protein α in immunotherapy for solid tumors
inferred← citeshttps://doi.org/10.3390/biomedicines13030661openalex-snapshot
Multi-Omics Analysis of the Anoikis Gene CASP8 in Prostate Cancer and Biochemical Recurrence (BCR)
inferred← citeshttps://doi.org/10.3390/cancers15082405openalex-snapshot
Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma
inferred← citeshttps://doi.org/10.3390/ijms25158523openalex-snapshot
Innate Immune Cells in Melanoma: Implications for Immunotherapy
inferred← citeshttps://doi.org/10.3390/ijms25179502openalex-snapshot
Deciphering Dormant Cells of Lung Adenocarcinoma: Prognostic Insights from O-glycosylation-Related Tumor Dormancy Genes Using Machine Learning
inferred← citeshttps://doi.org/10.51847/x0qetm8gyqopenalex-snapshot
Therapeutic Targeting of FGL1-Driven Lymph Node Metastasis in Stage T1 Non-Small Cell Lung Cancer
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.